Back to timeline
Verified
Hearing
Funding

Tabak testifies at 'Overseeing the Overseers' hearing on EcoHealth grant oversight

One day after HHS announced suspension and proposed debarment of EcoHealth Alliance, NIH Principal Deputy Director Lawrence Tabak testified under oath that NIH's forensic audit found no system lockout that would have prevented EcoHealth's on-time Year-5 report (contradicting Daszak's testimony), that NIH never received the requested WIV lab notebooks or metadata, and that increased viral growth 'does not necessarily mean increased pathogenicity.' He reiterated NIH's position that grant-studied viruses were too evolutionarily distant to be SARS-CoV-2's progenitor and that the funded work was not gain-of-function under the regulatory definition.

Linked sources

CHRG-118hhrg55710 — 'Overseeing the Overseers' hearing, May 16, 2024 (Serial No. 118-110)
Tier 1 · transcript · Tabak testimony; quotes the Oct. 20, 2021 Tabak letter verbatim

Related contentions

Gain-of-function definitions

Unresolved definitional dispute. Tabak letter (Oct 2021) acknowledged delayed reporting of enhanced growth in mice; NIH still denied ePPP classification.